Exact Sciences Corp (EXAS) concluded trading on Thursday at a closing price of $56.17, with 4.45 million shares of worth about $250.04 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 9.43% during that period and on May 15, 2025 the price saw a gain of about 2.37%. Currently the company’s common shares owned by public are about 188.59M shares, out of which, 185.76M shares are available for trading.
Stock saw a price change of 5.86% in past 5 days and over the past one month there was a price change of 28.62%. Year-to-date (YTD), EXAS shares are showing a performance of -0.04% which increased to 1.04% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $39.97 but also hit the highest price of $72.83 during that period. The average intraday trading volume for Exact Sciences Corp shares is 2.66 million. The stock is currently trading 14.39% above its 20-day simple moving average (SMA20), while that difference is up 21.10% for SMA50 and it goes to 0.18% higher than SMA200.
Exact Sciences Corp (NASDAQ: EXAS) currently have 188.59M outstanding shares and institutions hold larger chunk of about 98.54% of that.
The stock has a current market capitalization of $10.60B and its 3Y-monthly beta is at 0.97. It has posted earnings per share of -$5.50 in the same period. It has Quick Ratio of 2.38 while making debt-to-equity ratio of 1.06. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EXAS, volatility over the week remained 4.72% while standing at 4.78% over the month.
Analysts are in expectations that Exact Sciences Corp (EXAS) stock would likely to be making an EPS of 0.07 in the current quarter, while forecast for next quarter EPS is 0.14 and it is 0.98 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.03 which is 0.15 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.06 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 92.25% while it is estimated to increase by 191.00% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Mizuho on April 10, 2025 offering an Outperform rating for the stock and assigned a target price of $60 to it. Coverage by RBC Capital Mkts stated Exact Sciences Corp (EXAS) stock as a Sector perform in their note to investors on March 13, 2025, suggesting a price target of $52 for the stock. On January 23, 2025, Barclays Initiated their recommendations, while on August 28, 2024, Wells Fargo Initiated their ratings for the stock with a price target of $75. Stock get a Sector outperform rating from Scotiabank on June 27, 2024.
